Authors
  Mahesh Barai,  Suraj Kumar,  Abhishek Kumar,  Surakshya Kumari Tiwari,  Aditi Bhardwaj
Keywords
Covid-19, Corona virus, Vaccines, Monoclonal antibody, DNA
Abstract
COVID-19, a highly transmissible respiratory ailment, was initially identified in December 2019 in Wuhan, China. It swiftly spread worldwide and is attributed to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Notable variants such as Alpha, Beta, Delta, and Omicron have emerged, resulting in symptoms such as fever, cough, and breathing difficulties. As of 2023, approximately 770 million cases have been documented, with a tragic death toll of 6.9 million. Several factors contribute to increased COVID-19 morbidity among adults, including advanced age, male gender, pre-existing health conditions, and racial/ethnic disparities. Protective measures against SARS-CoV-2 infection encompass a adequate nutrition, COVID-19 vaccination, and the management of atopic conditions. The arsenal of tools to combat COVID-19 includes antiviral medications, steroids, chloroquine, convalescent plasma, vaccines, and monoclonal antibody treatments aimed at preventing severe illness. Broadly, there are six main categories into which potential vaccine candidates can be organized, each offering unique approaches to vaccination. These categories encompass viral vector-based vaccines, DNA vaccines, subunit vaccines, nanoparticle-based vaccines, inactivated-whole virus vaccines, and live-attenuated vaccines. Severe cases of COVID-19 are marked by rest-related shortness of breath and respiratory distress. A combination of techniques, such as genome sequencing, nucleic acid molecular testing, antigen/antibody detection, and computed tomography imaging, are employed to diagnose and screen for COVID-19 infection.
This review delves into the current state of knowledge, prevention strategies, treatment options, and the analysis of extensive vaccines related to COVID-19.
IJCRT's Publication Details
Unique Identification Number - IJCRT2402014
Paper ID - 249153
Page Number(s) - a133-a137
Pubished in - Volume 12 | Issue 2 | February 2024
DOI (Digital Object Identifier) -   
Publisher Name - IJCRT | www.ijcrt.org | ISSN : 2320-2882
E-ISSN Number - 2320-2882
Cite this article
  Mahesh Barai,  Suraj Kumar,  Abhishek Kumar,  Surakshya Kumari Tiwari,  Aditi Bhardwaj,   
"Diving into Diversity: A Comprehensive Review of COVID-19 Vaccine Varities.", International Journal of Creative Research Thoughts (IJCRT), ISSN:2320-2882, Volume.12, Issue 2, pp.a133-a137, February 2024, Available at :
http://www.ijcrt.org/papers/IJCRT2402014.pdf